Description
BlockRx is a blockchain-enabled platform developed by iSolve, focusing on transforming the pharmaceutical and healthcare industries through the utilization of Advanced Digital Ledger Technology (ADLT™). The platform aims to enhance drug development, supply chain integrity, and patient engagement by creating a secure and transparent ecosystem for data management and transactions. It achieves this by enabling the secure transfer of information, integrating IoT devices for real-time patient health monitoring, and facilitating collaboration among pharmaceutical companies, regulators, and healthcare providers. Key to its operation is the BlockRx Token (BKRX), which serves as the medium of exchange within the ecosystem, incentivizing data sharing and facilitating access to network services. By bridging the communication gap between various stakeholders, BlockRx aspires to improve patient outcomes, ensure drug traceability, meet regulatory compliance, and enhance patient safety, establishing a network of Trusted Partners through tokenized incentives and data provenance that meets both regulatory and business needs.
BlockRx is a blockchain-enabled platform developed by iSolve, focusing on transforming the pharmaceutical and healthcare industries through the utilization of Advanced Digital Ledger Technology (ADLT™). The platform aims to enhance drug development, supply chain integrity, and patient engagement by creating a secure and transparent ecosystem for data management and transactions. It achieves this by enabling the secure transfer of information, integrating IoT devices for real-time patient health monitoring, and facilitating collaboration among pharmaceutical companies, regulators, and healthcare providers. Key to its operation is the BlockRx Token (BKRX), which serves as the medium of exchange within the ecosystem, incentivizing data sharing and facilitating access to network services. By bridging the communication gap between various stakeholders, BlockRx aspires to improve patient outcomes, ensure drug traceability, meet regulatory compliance, and enhance patient safety, establishing a network of Trusted Partners through tokenized incentives and data provenance that meets both regulatory and business needs.
